After enzalutamide is reimbursed by medical insurance, how much will the patient pay out of pocket? What are the specific expenses and reimbursement ratio?

Enzalutamide (Enzalutamide) has been launched in China and has been included in the medical insurance system. However, due to its high price, patients still have to pay a certain out-of-pocket portion after medical insurance reimburses them. The following is a detailed analysis of the patient’s out-of-pocket portion after enzalutamide is reimbursed by medical insurance.

The market retail price of enzalutamide is approximately4,500 yuan. The specific price may vary depending on regions and pharmacies. Enzalutamide has been included in the medical insurance catalog if the patient meets the medical insurance conditions. Depending on the medical insurance policies of different regions, patients may enjoy a certain percentage of reimbursement. However, the specific reimbursement ratio will vary depending on regional medical insurance policies, medical insurance payment status, and the patient's medical insurance category.

Normally, the medical insurance reimbursement ratio depends on the city where the patient is located and the level of medical insurance. For example, in some big cities, the proportion of medical insurance reimbursement may be higher, while in other places, it may be relatively lower. Taking 4,500 yuan as an example, assuming that the medical insurance reimbursement ratio is 70%, the patient can be reimbursed 3,150 yuan, and the remaining 1,350 yuan needs to be paid by the patient himself. However, patients still need to consult the local hospital pharmacy for specific costs to confirm the detailed reimbursement ratio and out-of-pocket amount.

In foreign countries, the price of the original drug of enzalutamide is relatively high. For example, in Türkiye, the price of enzalutamide’s original drug is approximately 15,000 yuan, which is significantly higher than the domestic medical insurance price. At the same time, there are some cheaper generic versions on the market, mainly from places like India and Laos. The price of these generic drugs usually ranges from more than one thousand yuan to several thousand yuan, which is more affordable than the original drugs. Nonetheless, when choosing a generic drug, patients should ensure that the drug ingredients are consistent with the original drug and have been formally approved and certified.

Although the price of enzalutamide is higher, after being included in medical insurance, most patients can effectively reduce their burden under medical insurance reimbursement. For patients whose financial conditions permit, they can choose to purchase original drugs through medical insurance; for patients with limited financial conditions, generic drugs are also a feasible option, and the price is relatively low. Regardless of whether they choose original drugs or generic drugs, patients should purchase them through formal channels and use the drugs under the guidance of a doctor to ensure treatment effectiveness and safety. When purchasing, you should also understand the local hospital's medical insurance policy to ensure smooth reimbursement.

Reference materials:https://www.xtandi.com/